Literature DB >> 27780720

Unilateral olfactory sensitivity in multiple sclerosis.

Kimberley P Good1, Isabelle A Tourbier2, Paul Moberg3, Jennifer L Cuzzocreo4, Rena J Geckle5, David M Yousem5, Dzung L Pham6, Richard L Doty7.   

Abstract

It is not known whether lateralized olfactory sensitivity deficits are present in MS. Since projections from the olfactory bulb to the olfactory cortex are largely ipsilateral, and since both functional imaging and psychophysical studies suggest that the right side of the brain may be more involved in olfactory processing than the left, we addressed this issue by administering well-validated tests of odor detection, along with tests of odor identification, to each side of the nose of 73 MS patients and 73 age-, gender-, and race-matched normal controls. We also determined, in 63 of the MS patients, whether correlations were present between the olfactory test measures and MRI-determined lesions in brain regions ipsilateral and contralateral to the nose side that was tested. No significant left:right differences in either olfactory sensitivity or identification were present, although in both cases mean performance was lower in the MS than in the control subjects (ps<0.0001). Scores on the two sides of the nose were positively correlated with one another (threshold r=0.56, p<0.0001; Identification r=0.71, p<0.0001). The percent of MS patients whose bilateral test scores fell below the 10th percentile of controls did not differ between the odor identification and detection threshold tests. Both left and right odor identification and detection test scores were weakly correlated with lesion volumes in temporal and frontal lobe brain regions (r's<0.40). Our findings demonstrate that MS does not differentially influence odor perception on left and right sides of the nose, regardless of whether sensitivity or identification is being measured. They also indicate that tests of odor identification and detection are similarly influenced by MS and that such influences are associated with central brain lesions. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain laterality; Magnetic resonance imaging; Multiple sclerosis; Olfaction; Sex differences; Threshold; UPSIT

Mesh:

Year:  2016        PMID: 27780720      PMCID: PMC5135634          DOI: 10.1016/j.physbeh.2016.10.017

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  56 in total

1.  Unirhinal norms for the University of Pennsylvania Smell Identification Test.

Authors:  Kimberley P Good; Jeffrey S Martzke; Marie Abi Daoud; Lili C Kopala
Journal:  Clin Neuropsychol       Date:  2003-05       Impact factor: 3.535

2.  Pure-tone auditory thresholds are not chronically elevated in multiple sclerosis.

Authors:  Richard L Doty; Isabelle Tourbier; Sherrie Davis; Jennifer Rotz; Jennifer L Cuzzocreo; Jonathan Treem; Neil Shephard; Dzung L Pham
Journal:  Behav Neurosci       Date:  2012-02-06       Impact factor: 1.912

3.  Volumetric neuroimage analysis extensions for the MIPAV software package.

Authors:  Pierre-Louis Bazin; Jennifer L Cuzzocreo; Michael A Yassa; William Gandler; Matthew J McAuliffe; Susan S Bassett; Dzung L Pham
Journal:  J Neurosci Methods       Date:  2007-05-29       Impact factor: 2.390

4.  Right-nostril advantage for discrimination of odors.

Authors:  R J Zatorre; M Jones-Gotman
Journal:  Percept Psychophys       Date:  1990-06

5.  Tests of human olfactory function: principal components analysis suggests that most measure a common source of variance.

Authors:  R L Doty; R Smith; D A McKeown; J Raj
Journal:  Percept Psychophys       Date:  1994-12

6.  A study of the test-retest reliability of ten olfactory tests.

Authors:  R L Doty; D A McKeown; W W Lee; P Shaman
Journal:  Chem Senses       Date:  1995-12       Impact factor: 3.160

7.  Olfaction in multiple sclerosis. With a note on the discrepancy between optic and olfactory involvement.

Authors:  K A Ansari
Journal:  Eur Neurol       Date:  1976       Impact factor: 1.710

8.  Prevalence of olfactory impairment in older adults.

Authors:  Claire Murphy; Carla R Schubert; Karen J Cruickshanks; Barbara E K Klein; Ronald Klein; David M Nondahl
Journal:  JAMA       Date:  2002-11-13       Impact factor: 56.272

9.  Taste dysfunction in multiple sclerosis.

Authors:  Richard L Doty; Isabelle A Tourbier; Dzung L Pham; Jennifer L Cuzzocreo; Jayaram K Udupa; Bilge Karacali; Evan Beals; Laura Fabius; Fidias E Leon-Sarmiento; Gul Moonis; Taehoon Kim; Toru Mihama; Rena J Geckle; David M Yousem
Journal:  J Neurol       Date:  2016-01-25       Impact factor: 4.849

10.  Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration.

Authors:  R L Doty; D A Deems; S Stellar
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

View more
  4 in total

1.  Balance in multiple sclerosis: relationship to central brain regions.

Authors:  Richard L Doty; Michael R MacGillivray; Hussam Talab; Isabelle Tourbier; Megan Reish; Sherrie Davis; Jennifer L Cuzzocreo; Neil T Shepard; Dzung L Pham
Journal:  Exp Brain Res       Date:  2018-07-17       Impact factor: 1.972

2.  Olfaction and taste in Parkinson's disease: the association with mild cognitive impairment and the single cognitive domain dysfunction.

Authors:  Maria Paola Cecchini; Angela Federico; Alice Zanini; Elisa Mantovani; Carla Masala; Michele Tinazzi; Stefano Tamburin
Journal:  J Neural Transm (Vienna)       Date:  2019-03-25       Impact factor: 3.575

3.  Olfactory system measurements in COVID-19: a systematic review and meta-analysis.

Authors:  Soheil Mohammadi; Mahdi Gouravani; Mohammad Amin Salehi; Hamid Harandi; Fatemeh Moosaie; Fatemeh Dehghani Firouzabadi; David M Yousem
Journal:  Neuroradiology       Date:  2022-07-18       Impact factor: 2.995

4.  Change in Functional Brain Activation Patterns Induced by Olfactory Stimulation in Multiple Sclerosis.

Authors:  Qingrong OuYang; Yinxu Wang; Yun-Wei Zhang; Ming Yu; Xiaoming Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-06-09       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.